Table 2.
Study ID | First Author Year of Publication | Year of Data Collection^ |
WHO Region | WHO Mortality Strata |
Country | Diagnostic Method* | Population TB +ve Screening Screened Screened# (n) Method≠ Population (n) % Male |
Population | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Bhat, 2009 | 2007–2008 | SEAR | D | India | Culture | 22,284 | 83 | Chest symptoms | 48.6 | |||||||
2 | Bhat, 2015 | 2012–2013 | SEAR | D | India | Culture | 19,409 | 494 | Chest symptoms | ||||||||
3 | Bhat, 2017 | 2013 | SEAR | D | India | Culture | 12,123 | 348 | Chest symptoms | ||||||||
4 | Bolton, 1975 | 1961–1971 | WPR | B | Malaysia | Smear | 71,748 | 249 | X-ray | ||||||||
5 | Chakma, 1996 | <1996 | SEAR | D | India | Culture | 11,097 | 142 | Chest symptoms | ||||||||
6 | Damon, 1974 | 1968 | WPR | B | Solomon Is | Clinical | 850 | 21 | No pre-screening | ||||||||
7 | Datta, 2001 | 1989 | SEAR | D | India | Culture | 16,017 | 126 | Chest symptoms +/or x-ray | 60.2 | |||||||
8 | Haddad, 2012 | <2012 | SEAR | D | India | Smear | 1,660 | 346 | Chest symptoms | ||||||||
9 | Hussain, 2020 | 2015–2017 | SEAR | D | India | Culture | 5,145 | 35 | Chest symptoms | ||||||||
10 | Kashyap, 2013 | <2013 | SEAR | D | India | Culture | 128 | 41 | No pre-screening | ||||||||
11 | Kerketta, 2009 | <2009 | SEAR | D | India | Clinical | 314 | 12 | No pre-screening | 43.0 | |||||||
12 | King, 1951 | 1950 | WPR | A | Australia | Clinical | 3,209 | 15 | Mantoux test | ||||||||
13 | Macken, 1952 | 1949–1951 | WPR | A | Australia | Clinical | 5,472 | 177 | Mantoux test | ||||||||
14 | Murhekar, 2004 | 2001–2002 | SEAR | D | India | Smear | 10,570 | 77 | Chest symptoms | ||||||||
15 | Purty, 2019 | 2015–2017 | SEAR | D | India | Smear | 6,898 | 18 | Chest symptoms | 47.8 | |||||||
16 | Rao, 2010A | 2008 | SEAR | D | India | Culture | 1,390 | 6 | Chest symptoms | ||||||||
17 | Rao, 2010B | 2007–2008 | SEAR | D | India | Culture | 11,116 | 166 | Chest symptoms | ||||||||
18 | Rao, 2011 | 2007–2008 | SEAR | D | India | Culture | 9,538 | 133 | Chest symptoms | 47.6 | |||||||
19 | Rao, 2015 | 2012–2013 | SEAR | D | India | Culture | 9,653 | 318 | Chest symptoms | 46.5 | |||||||
20 | Rao, 2019 | 2013 | SEAR | D | India | Culture | 9,756 | 293 | Chest symptoms | ||||||||
21 | Roy, 1969 | 1968 | WPR | B | Malaysia | Smear | 1,055 | 108 | X-ray | 55 | |||||||
22 | Sharma, 2010 | 2006–2007 | SEAR | D | India | Smear | 50,000 | 266 | Chest symptoms | ||||||||
23 | Vyas, 2019 | 2014–2015 | SEAR | D | India | Smear | 65,230 | 964 | Chest symptoms | ||||||||
24 | Yano, 1974 | 1972 | WPR | B | Malaysia | Clinical | 562 | 12 | No pre-screening |
Notes:^ If the study has not detailed the year of data collection, it is assumed < year of publication
*Diagnostic method: Smear = smear or uncategorized sputum methodology. Clinical = current TB treatment, self-report, X-ray. If a paper uses multiple methods, it is classified according to the most sensitive method according to the following descending order: culture, smear and clinical (e.g. if smear + culture classified as culture, if x-ray and smear classified as smear)
# Population figures are inclusive of non-indigenous participants in the comparative studies
≠Where studies utilize a screening method to determine the population to be tested, this is detailed. Chest symptoms include-persistent cough, chest pain, fever, hemoptysis.